JP5089185B2 - コラーゲン産生抑制剤。 - Google Patents

コラーゲン産生抑制剤。 Download PDF

Info

Publication number
JP5089185B2
JP5089185B2 JP2007021396A JP2007021396A JP5089185B2 JP 5089185 B2 JP5089185 B2 JP 5089185B2 JP 2007021396 A JP2007021396 A JP 2007021396A JP 2007021396 A JP2007021396 A JP 2007021396A JP 5089185 B2 JP5089185 B2 JP 5089185B2
Authority
JP
Japan
Prior art keywords
group
phenyl
substituent
lower alkyl
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2007021396A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007231005A (ja
JP2007231005A5 (enExample
Inventor
多恵 福島
憲昭 武村
国憲 田井
仁 永尾
展明 伊藤
崇 中川
英樹 高須
研二 渡邊
修二 松村
卓也 志津田
誠 坂元
慶三 菅
啓介 宮嶋
理紀 田中
英昭 佐藤
啓徳 筒井
敏 山田
裕 小島
貢一 安村
直人 大井
貢広 奥野
和久 杉山
邦彦 清野
敬 鈴木
聖司 赤松
健志 児玉
康夫 柳原
卓美 住田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP2007021396A priority Critical patent/JP5089185B2/ja
Publication of JP2007231005A publication Critical patent/JP2007231005A/ja
Publication of JP2007231005A5 publication Critical patent/JP2007231005A5/ja
Application granted granted Critical
Publication of JP5089185B2 publication Critical patent/JP5089185B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2007021396A 2006-02-02 2007-01-31 コラーゲン産生抑制剤。 Expired - Fee Related JP5089185B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007021396A JP5089185B2 (ja) 2006-02-02 2007-01-31 コラーゲン産生抑制剤。

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006025329 2006-02-02
JP2006025329 2006-02-02
JP2007021396A JP5089185B2 (ja) 2006-02-02 2007-01-31 コラーゲン産生抑制剤。

Publications (3)

Publication Number Publication Date
JP2007231005A JP2007231005A (ja) 2007-09-13
JP2007231005A5 JP2007231005A5 (enExample) 2010-03-18
JP5089185B2 true JP5089185B2 (ja) 2012-12-05

Family

ID=38551949

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007021396A Expired - Fee Related JP5089185B2 (ja) 2006-02-02 2007-01-31 コラーゲン産生抑制剤。

Country Status (1)

Country Link
JP (1) JP5089185B2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006040329A1 (en) 2004-10-12 2006-04-20 Novo Nordisk A/S 1 ibeta- hydroxysteroid dehydrogenase type 1 active spiro compounds
BRPI0618051A2 (pt) 2005-11-01 2011-08-16 Transtech Pharma Inc uso farmacêutico de amidas substituìdas
US8053447B2 (en) 2006-04-07 2011-11-08 High Point Pharmaceuticals, Llc 11β-hydroxysteroid dehydrogenase type 1 active compounds
EP2044073A1 (en) 2006-07-13 2009-04-08 High Point Pharmaceuticals, LLC 11beta-hydroxysteroid dehydrogenase type 1 active compounds
MX2009008228A (es) 2007-02-23 2009-08-12 High Point Pharmaceuticals Llc N-adamantil benzamidas como inhibidores de la dehidrogenasa 11-beta-hidroxiesteroide.
JP2010519242A (ja) 2007-02-23 2010-06-03 ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー 新規化合物
EP2134705A1 (en) 2007-03-09 2009-12-23 High Point Pharmaceuticals, LLC Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors
CN101711106B (zh) 2007-04-24 2013-02-06 高点制药有限责任公司 取代的酰胺类的药物应用
EA020496B1 (ru) 2008-11-21 2014-11-28 ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Производное адамантилбензамида, фармацевтическая композиция, включающая его, и его применение
HRP20150355T1 (hr) 2009-01-12 2015-06-19 Pfizer Limited Sulfonamidni derivati
JP5688918B2 (ja) * 2009-04-28 2015-03-25 大塚製薬株式会社 医薬組成物
WO2011047156A1 (en) * 2009-10-15 2011-04-21 Hercules Technology Management Co V, Inc. Sepiapterin reductase inhibitors for the treatment of pain
CN108721621B (zh) * 2017-04-14 2022-03-01 中国科学院上海高等研究院 抑制肝纤维化的小分子化合物及应用
JP7444458B2 (ja) * 2018-09-21 2024-03-06 学校法人福岡大学 プリオン病治療薬
CN118765280A (zh) * 2022-02-28 2024-10-11 维泰瑞隆有限公司 Rip1调节剂、其制备及用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001089412A (ja) * 1999-09-22 2001-04-03 Otsuka Pharmaceut Co Ltd ベンゼン誘導体またはその医薬的に許容される塩
JP2001089450A (ja) * 1999-09-22 2001-04-03 Otsuka Pharmaceut Co Ltd ピリジン誘導体含有医薬製剤

Also Published As

Publication number Publication date
JP2007231005A (ja) 2007-09-13

Similar Documents

Publication Publication Date Title
JP4154613B2 (ja) 芳香族化合物
JP5089185B2 (ja) コラーゲン産生抑制剤。
JP5068821B2 (ja) Stat3/5活性化阻害剤
US8236826B2 (en) Diarylether derivatives as antitumor agents
JP5142513B2 (ja) 医薬
HK1101824B (en) Aromatic compounds
MX2008006849A (en) Diarylether derivatives as antitumor agents
HK1123219B (en) Diarylether derivatives as antitumor agents
HK1131619B (en) Stat3/5 activation inhibitor

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100127

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100127

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120821

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120911

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150921

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees